UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014489
Receipt number R000016851
Scientific Title The change of endothelial function of preeclampsia patients during the treatments
Date of disclosure of the study information 2014/07/14
Last modified on 2020/01/09 09:43:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The change of endothelial function of preeclampsia patients during the treatments

Acronym

Endothelial dysfunction of preeclampsia

Scientific Title

The change of endothelial function of preeclampsia patients during the treatments

Scientific Title:Acronym

Endothelial dysfunction of preeclampsia

Region

Japan


Condition

Condition

preeclampsia and pregnancy induced hypertension

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate whether the treatments for preeclampsia (bed rest, blood pressure-lowering drugs, and MgSO4) improve the endothelial dysfunction in preeclmapsia patients.

Basic objectives2

Others

Basic objectives -Others

To evaluate whether the improvement of endothelial dysfuntion contributes the better perinatal prognosis.

Trial characteristics_1

Others

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

the change of endothelial function

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

normal, no medication

Interventions/Control_2

pregnancy induced hypertension, bed rest, blood pressure-lowering drugs

Interventions/Control_3

preeclampsia, bed rest, blood pressure-lowering drugs, MgSO4

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Pregnancy induced hypertension and preeclampsia.

Key exclusion criteria

the cases with complication of pheochromocytoma.

Target sample size

90


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahide Ohmichi

Organization

Osaka Medical College

Division name

Obstetrics and Gynecology

Zip code


Address

2-7 Daigaku-machi, Takatsuki city, Osaka, Japan

TEL

+81-72-683-1221

Email

m-ohmichi@osaka-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akiko Tanabe

Organization

Osaka Medical College

Division name

Obstetrics and Gynecology

Zip code


Address

2-7 Daigaku-machi, Takatsuki city, Osaka, Japan

TEL

+81-72-683-1221

Homepage URL


Email

gyn074@osaka-med.ac.jp


Sponsor or person

Institute

Dept. of Obstetrics and Gynecology
Osaka Medical College

Institute

Department

Personal name



Funding Source

Organization

Dept. of Obstetrics and Gynecology
Osaka Medical College

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 07 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 07 Month 07 Day

Date of IRB

2014 Year 06 Month 30 Day

Anticipated trial start date

2014 Year 07 Month 08 Day

Last follow-up date

2017 Year 06 Month 30 Day

Date of closure to data entry

2018 Year 12 Month 31 Day

Date trial data considered complete

2018 Year 12 Month 31 Day

Date analysis concluded

2019 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2014 Year 07 Month 06 Day

Last modified on

2020 Year 01 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016851


Research Plan
Registered date File name
2018/01/08 PE_FMDプロトコル.doc

Research case data specifications
Registered date File name
2018/01/08 岡本研究計画書H26年度.docx

Research case data
Registered date File name
2018/01/08 成果発表会2016.pptx